Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

Item
http://www.wikidata.org/entity/Q33359794
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular RetinoblastomaCamptothecin-based regimens for treatment of ewing sarcoma: past studies and future directionsFormulations for children: problems and solutionsA single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-upPopulation Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.Rapid screening of novel agents for combination therapy in sarcomasA comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.
P2860

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors.

Item
http://www.wikidata.org/entity/Q33359794
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@ast
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@en
type
label
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@ast
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@en
prefLabel
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@ast
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Phase I and pharmacokinetic st ...... with refractory solid tumors.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698